Mwandishi:
Mhariri:
Imeboershwa:
ULY CLINIC
ULY CLINIC
10 Julai 2026, 10:54:16
Acne
Acne is a multifactorial chronic inflammatory disease of the pilosebaceous unit, most common during adolescence but may persist into adulthood.
It results from a combination of:
Increased sebum production (androgen-driven)
Follicular hyperkeratinization (plugging)
Colonization with Cutibacterium acnes
Inflammation
It presents with polymorphic lesions affecting mainly the face, chest, shoulders, and back.
Acne can significantly affect psychological well-being, causing low self-esteem, anxiety, and depression.
Epidemiology
Common in teenagers (peak 15–19 years)
Can affect adults, especially women
More severe in males during adolescence
Often worsens with hormonal changes
Risk Factors
Puberty (androgen surge)
Family history
Oily cosmetics
Steroids (systemic or topical)
Anticonvulsants
Lithium
Polycystic ovarian syndrome (PCOS)
Stress
High glycemic index diet
Pathophysiology
Four key mechanisms:
Follicular plugging (microcomedone formation)
Increased sebum production
Bacterial proliferation (C. acnes)
Inflammatory response
This leads to formation of comedones, papules, pustules, nodules, and cysts.
Clinical Types
Non-inflammatory acne
Open comedones (blackheads)
Closed comedones (whiteheads)
Inflammatory acne
Papules
Pustules
Nodules
Cysts
Severe variants
Nodulocystic acne
Acne conglobata
Acne fulminans (rare, systemic symptoms present)
Signs & Symptoms
Open and closed comedones
Pustules
Nodular lesions
Cystic lesions
Oily skin
Post-inflammatory hyperpigmentation
Scarring (ice-pick, boxcar, rolling scars)
Commonly involves:
Face
Chest
Shoulders
Back
Diagnostic Criteria
Clinical diagnosis based on:
Presence of comedones (essential for diagnosis)
Inflammatory lesions (papules, pustules, nodules)
Distribution on sebaceous areas
Chronic or relapsing course
No laboratory test is required for routine cases.
Investigations
Usually not required.
Consider in selected cases:
Hormonal profile (if irregular menses, hirsutism suspected PCOS)
Fasting blood sugar (if metabolic syndrome suspected)
Liver function tests (before isotretinoin)
Lipid profile (before isotretinoin)
Pregnancy test (before isotretinoin in females)
Treatment
Treatment depends on severity.
Non-Pharmacological Treatment
Avoid precipitating factors (stress, oily cosmetics, steroids)
Avoid picking or squeezing lesions
Use mild soap and lukewarm water
Avoid harsh antibacterial cleansers
Maintain healthy lifestyle (exercise, balanced diet)
Avoid excessive use of ointments
Reduce high glycemic foods
Pharmacological Treatment
Mild to moderate acne (Without scarring)
Apply:
Benzoyl peroxide (topical) 2.5%–5% — apply once at night
OR
Tretinoin cream (topical) 0.05% — apply once at night
Moderate acne with scarring
Doxycycline (PO) 100 mg once daily for 1–3 months
OR
Erythromycin (PO) 250 mg every 6 hours for 1–3 months
AND
Benzoyl peroxide (topical) 2.5%–5% once at night or
Tretinoin cream (topical) 0.05% once at night
Nodulocystic and/or Conglobate Acne
Isotretinoin (PO) 0.025–0.5 mg/kg once daily for at least 3–6 months
AND
Triamcinolone (intralesional) 40 mg/mL — administer as a single dose (stat) for acne cysts
Monitoring during isotretinoin therapy:
Liver function tests
Lipid profile
Pregnancy test (mandatory in females of reproductive age)
Acne fulminans
Isotretinoin (PO) 0.025–0.5 mg/kg once daily for at least 4–6 months
AND
Prednisolone (PO) 45 mg as a single initial dose (stat), then reduce by 5 mg daily until discontinued
Important note
Isotretinoin is contraindicated during pregnancy because it is highly teratogenic. Effective pregnancy prevention is essential before, during, and for an appropriate period after treatment.
Complications
Permanent scarring
Hyperpigmentation
Psychological distress
Depression
Prevention
Avoid triggering factors
Avoid self-medication
Early treatment to prevent scarring
Proper skin hygiene
Healthy diet and lifestyle
Avoid steroid misuse
Imeandikwa;
3 Novemba 2020, 15:32:28
